Live two-way video versus face-to-face treatment for depression, anxiety, and obsessive-compulsive disorder: A 24-week randomized controlled trial.
Autor: | Kishimoto T; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan., Kinoshita S; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.; Graduate School of Interdisciplinary Information Studies, The University of Tokyo, Tokyo, Japan., Kitazawa M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Hishimoto A; Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan., Asami T; Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan., Suda A; Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan.; Psychiatric Center, Yokohama City University Medical Center, Yokohama, Japan., Bun S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Sato Hospital, Yamagata, Japan., Kikuchi T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Sado M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Takamiya A; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Akasaka Clinic, Tokyo, Japan., Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Sato Y; Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan., Takemura R; Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan., Nagashima K; Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan., Nakamae T; Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Abe Y; Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kanazawa T; Department of Neuropsychiatry, Osaka Medical and Pharmaceutical University, Osaka, Japan., Kawabata Y; Department of Neuropsychiatry, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tomita H; Department of Psychiatry, Tohoku University Hospital, Sendai, Japan.; Department of Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan., Abe K; Department of Psychiatry, Tohoku University Hospital, Sendai, Japan., Hongo S; Himorogi Psychiatric Institute, Tokyo, Japan., Kimura H; Department of Psychiatry, Gakuji-kai Kimura Hospital, Chiba, Japan.; Department of Psychiatry, School of Medicine, International University of Health and Welfare, Chiba, Japan., Sato A; Department of Psychiatry, School of Medicine, International University of Health and Welfare, Chiba, Japan., Kida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Asaka Hospital, Fukushima, Japan., Sakuma K; Asaka Hospital, Fukushima, Japan., Funayama M; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Tochigi, Japan., Sugiyama N; Numazu Chuo Hospital, Shizuoka, Japan., Hino K; Numazu Chuo Hospital, Shizuoka, Japan., Amagai T; Amagai Mental Clinic, Yokohama, Japan., Takamiya M; Takamiya Hospital, Miyazaki, Japan., Kodama H; Takamiya Hospital, Miyazaki, Japan., Goto K; Shioiri Mental Clinic, Yokosuka, Japan., Fujiwara S; Kanazawabunko Yell Clinic, Yokohama, Japan., Kaiya H; Akasaka Clinic, Tokyo, Japan., Nagao K; Neyagawa Sanatoriumu, Osaka, Japan. |
---|---|
Jazyk: | angličtina |
Zdroj: | Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2024 Apr; Vol. 78 (4), pp. 220-228. Date of Electronic Publication: 2023 Dec 15. |
DOI: | 10.1111/pcn.13618 |
Abstrakt: | Aim: Live two-way video, easily accessible from home via smartphones and other devices, is becoming a new way of providing psychiatric treatment. However, lack of evidence for real-world clinical setting effectiveness hampers its approval by medical insurance in some countries. Here, we conducted the first large-scale pragmatic, randomized controlled trial to determine the effectiveness of long-term treatment for multiple psychiatric disorders via two-way video using smartphones and other devices, which are currently the primary means of telecommunication. Methods: This randomized controlled trial compared two-way video versus face-to-face treatment for depressive disorder, anxiety disorder, and obsessive-compulsive disorder in the subacute/maintenance phase during a 24-week period. Adult patients with the above-mentioned disorders were allocated to either a two-way video group (≥50% video sessions) or a face-to-face group (100% in-person sessions) and received standard treatment covered by public medical insurance. The primary outcome was the 36-Item Short-Form Health Survey Mental Component Summary (SF-36 MCS) score. Secondary outcomes included all-cause discontinuation, working alliance, adverse events, and the severity rating scales for each disorder. Results: A total of 199 patients participated in this study. After 24 weeks of treatment, two-way video treatment was found to be noninferior to face-to-face treatment regarding SF-36 MCS score (48.50 vs 46.68, respectively; p < 0.001). There were no significant differences between the groups regarding most secondary end points, including all-cause discontinuation, treatment efficacy, and satisfaction. Conclusion: Two-way video treatment using smartphones and other devices, was noninferior to face-to-face treatment in real-world clinical settings. Modern telemedicine, easily accessible from home, can be used as a form of health care. (© 2023 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.) |
Databáze: | MEDLINE |
Externí odkaz: |